Eisai seeks expanded use of Alzheimer's drug for prevention
Published
TOKYO -- Japanese drugmaker Eisai will apply for regulatory approval in the U.S. for preventative use of Alzheimer's drug, lecanemab as soon as the fiscal year starting April 2026. Lecanemab, if it proves safe and effective, would enable prevention of the disease in its early stages, potentially…
#tokyo #eisai #leqembi